Business Wire | May 3, 2021 08:00AM EDT

bluebird bio Announces May Investor Events

May 03, 2021

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 03, 2021--bluebird bio, Inc. (NASDAQ: BLUE) today announced that members of the management team will participate in the following upcoming investor conferences:

* BofA Securities 2021 Health Care Conference, Thursday, May 13, at 9:30 am ET * 2021 RBC Capital Markets Global Healthcare Conference, Wednesday, May 19, at 1:55 pm ET

To access the live webcast of bluebird bio's presentations, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at http://investor.bluebirdbio.com. A replay of the webcasts will be available on the bluebird bio website for 90 days following the event.

About bluebird bio, Inc.

bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we're developing gene and cell therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond our labs, we're working to positively disrupt the healthcare system to create access, transparency and education so that gene therapy can become available to all those who can benefit.

bluebird bio is a human company powered by human stories. We're putting our care and expertise to work across a spectrum of disorders: cerebral adrenoleukodystrophy, sickle cell disease, -thalassemia and multiple myeloma, using gene and cell therapy technologies including gene addition, and (megaTAL-enabled) gene editing.

bluebird bio has additional nests in Seattle, Wash.; Durham, N.C.; and Zug, Switzerland. For more information, visit bluebirdbio.com.

Follow bluebird bio on social media: @bluebirdbio, LinkedIn, Instagram and YouTube.

bluebird bio is a trademark of bluebird bio, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005391/en/

CONTACT: Investors & Media

CONTACT: Investors:

CONTACT: Ingrid Goldberg, 857-217-0490 igoldberg@bluebirdbio.com

CONTACT: Elizabeth Pingpank, 617-914-8736 epingpank@bluebirdbio.com

CONTACT: Media:

CONTACT: Jenn Snyder, 617-448-0281 jsnyder@bluebirdbio.com

CONTACT: Catherine Falcetti, 617-583-3411 cfalcetti@bluebirdbio.com